Total 141021 resultPre Next
Kimberly-Clark Declares Dividend Increase By:Kimberly-Clark Corporation 2025-01-28
DALLAS, Jan. 28, 2025 - The board of directors of Kimberly-Clark Corporation (NYSE: KMB) has declared an increased quarterly dividend of $1.26 per share, a level 3.3 percent higher than its previous regular quarterly payout. ...
Milk Makeup to Launch at Ulta Beauty This Spring By:Milk Makeup 2025-01-28
NEW YORK, Jan. 28, 2025 - Milk Makeup, the trailblazing clean beauty brand celebrated for its iconic, high-performance formulas, inclusive ethos and part of the Waldencast plc (NASDAQ: WALD) platform, is thrilled to announce an&nb...
RentRedi and Utility Connect Make Moving Easier for Renters By:RentRedi 2025-01-28
Access to Utility Connect's Concierge Service Provides RentRedi Tenants with Choice, Cost Savings, and a Stress-free Move-in Experience NEW YORK, Jan. 28, 2025 - RentRedi, the fastest-growing all-in-one property management software that makes&nb...
Robert T. Montgomery Commemorates Over 50 Years in Real Estate By:Marquis Who's Who Ventures LLC 2025-01-27
KILLINGTON, VT, January 27, 2025 - Robert T. Montgomery has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Fact...
Jeffrey Silberschlag Celebrated for Dedication to the Field of Music By:Marquis Who's Who Ventures LLC 2025-01-27
LEONARDTOWN, MD, January 27, 2025 - Jeffrey Silberschlag has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors&...
Baller Mixed Reality Announces Pre-Sale of B100 Crypto Token By:Baller Mixed Reality 2025-01-27
MIAMI BEACH, FL, January 27, 2025 - Baller Mixed Reality, recognized among the top sports technology and cryptocurrency startups in the United States by Crunchbase and F6S, is excited to announce the official launch of the&nb...
Seeking Investors: First-in-Class Immunotherapeutics for Cancer By:Cambium Oncology 2025-01-27
ATLANTA, Jan. 27, 2025 - Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical studies. The drug is mutation-agnostic, and the com...
Comply365 Announces Acquisition of ASQS By:Comply365 2025-01-27
Accelerates investment in safety management to create a leading global all-in-one operational content, safety and training management offering BELOIT, Wis. and BRISTOL, England and VIENNA, Jan. 27, 2025 - Comply365, LLC ("Comply365"), ...
